BioSpace News Archive

Drug Development

Alnylam to Report New Clinical Results from the APOLLO Phase 3 Study of Patisiran at the 16th International Symposium on Amyloidosis

The APOLLO Phase 3 study of patisiran is an investigational therapeutic for the treatment of hereditary ATTR (hATTR) amyloidosis.

March 14, 2018
·
12 min read
FDA

Jupiter Orphan Therapeutics Announces Submission of Investigational New Drug Application (IND) For Treatment Of Mucopolysaccharidosis Type-I

Jupiter Orphan Therapeutics, Inc. (“JOT”), Jupiter, FL, today announced that it had submitted its IND to the FDA on March 12, 2018 for Mucopolysaccharidosis Type-I (MPSI).

March 14, 2018
·
3 min read
BioMidwest

On Target Laboratories Raises Additional Capital from H.I.G. BioHealth Partners, Elevate Ventures and Helsinn

These recent raises bring the total financing round close to $44 million.

March 14, 2018
·
5 min read
Pharm Country

Bridge Medicines Accepts Novel Small Molecule Targeting Basal Cell Carcinoma As First Drug Candidate for Development

Project Originated at Rockefeller University and Graduated From Tri-Institutional Therapeutics Discovery Institute

March 14, 2018
·
4 min read
FDA

Amneal Gains Approval for Erythromycin Tablets USP

Amneal Pharmaceuticals has received FDA approval for Erythromycin Tablets USP, 250 mg and 500 mg strengths.

March 14, 2018
·
2 min read
Business

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results

BioSpecifics reported net income of $2.6 million for the fourth quarter ended December 31, 2017.

March 14, 2018
·
16 min read
Business

IQVIA Forms Alliance with Box to Provide Revolutionary, Cloud-Based Content Management Solutions to the Life Sciences and Healthcare Industries

IQVIA announced at the eyeforpharma conference that it has entered into an alliance with Box, a leading cloud content management platform provider.

March 14, 2018
·
2 min read
BioMidwest

GenomOncology Announces Working with Personalis to Improve Clinical Cancer Reporting Using GO Pathology Workbench

GenomOncology announced that Personalis is now using the GO Pathology Workbench system as part of their clinical cancer reporting process, enabling return of clinical cancer reports to ordering physicians more rapidly and in an intuitive format that aids their decision making.

March 14, 2018
·
2 min read
Business

TapImmune to Present at Two Upcoming Investor Conferences

TapImmune Inc. announced that its President and CEO, Peter Hoang, will participate in a panel discussion and give a company presentation at the Sachs BioCapital USA Forum, held March 21st, 2018.

March 14, 2018
·
1 min read
Business

Bruker Appoints Gerald Herman as Interim Chief Financial Officer

Bruker today announced that it has appointed Gerald N. Herman to serve as the Company’s Interim Chief Financial Officer (CFO), effective as of March 17, 2018.

March 14, 2018
·
3 min read